Tuesday, February 8, 2011

Dosage regimen is not patentable: EU Judgement

What is patentable and what is not is always remain unclear by reading the simple lines of legislation and its just a simple words but when we interpret, it always lead to many meanings.
Recently in a decision, in case of Actavis Vs Merck related to a patent of dosage regimen, they held patent invalid as the subject matter is not in the scope of patentability under article 53(c) EPC 2000.
For full judgement please click here (Source: Kluwer patent blog)

No comments:

Post a Comment